Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-09-053886
Filing Date
2009-11-20
Accepted
2009-11-20 18:48:26
Documents
1
Period of Report
2008-11-18

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c92969_4ax0.html 4/A  
1 MAIN DOCUMENT DESCRIPTION c92969_4ax0.xml 4/A 6369
  Complete submission text file 0001209191-09-053886.txt   8426
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50626 | Film No.: 091199949